ARQT Exercise Disclosure
Curran Terrie · SEC Form 4 · Filed Aug 28, 2026
Exercise
Calculated transaction value
$0
Curran Terrie Director
ARQT
Transaction date
Aug 27, 2026
Public filing date
Aug 28, 2026
Filing lag
Filed 1 day later
ARQT daily price context
Close on/before transaction
$24.87
Aug 27, 2026
Close before public filing
$24.87
Aug 27, 2026
Return since public filing
-5.43%
Through Sep 15, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (right to buy) on Common Stock
- Quantity / price
- 27,052 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001628280-26-059444
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$1.27M
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Arcutis Biotherapeutics, Inc. ARQT | Exercise | Aug 27, 2026 | $0 |
| Arcutis Biotherapeutics, Inc. ARQT | Exercise | Aug 27, 2026 | $83.72K |
| Arcutis Biotherapeutics, Inc. ARQT | Sale | Aug 27, 2026 | $677.1K |
| Arcutis Biotherapeutics, Inc. ARQT | Sale | Aug 27, 2026 | $279.03K |
| Arcutis Biotherapeutics, Inc. ARQT Current | Exercise | Aug 27, 2026 | $0 |
| Arcutis Biotherapeutics, Inc. ARQT | Exercise | Aug 27, 2026 | $233.46K |